DDP Video Testimonials & Interviews
2012 Attendee Testimonials
A Look at Drug Delivery Partnerships
Drug Delivery Partnerships has proven time and again to be THE meeting
place to discover innovative products, anticipate and take advantage of
trends in the partnering landscape and implement best practices to ensure
your company stays ahead of the curve. DDP TV 2012 Interviews
Michael Kaufman, Millenium Pharmaceuticals
In this episode of DDP TV, Michael Kaufman, Vice President, Pharmaceutical Sciences, Millennium Pharmaceuticals, discusses market dynamics, state of the drug delivery industry and partnering strategy.
Robert J. Bloder, Vice President, Business Development, AVEVA Drug Delivery Systems
In this episode of DDP TV, Robert Bloder discusses the changing face of drug delivery, emerging challengesand opportunities.
Marc Koska, Inventor of the K1 syringe and founder of the SafePoint Trust
In this episode of DDP TV, Marc Koska shares his K1 story: lessons learned in the front lines of a man-made epidemic.
Anand Subramony, Novartis Institutes for BioMedical Research, Inc.
In this edition of DDP TV, Anand discusses the emerging trends and technology, unmet needs and holy grails and partnering with delivery companies.
Dr. Geoffrey Hird, Eisai Inc.
In this episode of DDP TV, Dr. Geoffrey Hird, Principal Scientist, Global Formulation and Drug Delivery Technology Group, Eisai Inc. discusses engaging internal clients early in the development process, in-house capabilities versus outsourcing.DDP 2012 Presentations
Emerging Markets and in Drug Delivery
It's estimated that by 2020, the GDP of the seven major emerging countries could account for close to 14 percent of a projected global pharmaceutical market of $800 billion. With this significant a slice of the pie at stake, pharma needs to know what it will take to successfully enter emerging markets with their products. For the drug delivery sector, it is important to uncover opportunities early and understand the wants and needs -- and potential barriers -- to these new populations.
The Globalization of the Pharmaceutical and Biotechnology Industry
G. Steven Burrill, CEO, Burrill & Company outlines how ex-US/EU/Japan countries are taking more control of the pharmaceutical and biotechnology landscape and how their emergence will affect your future business development.
